Bill > A06475

This bill requires health insurance policies in New York to provide full coverage for comprehensive genetic testing and FDA-approved biomarker testing for ovarian and prostate cancers, with no out-of-pocket costs to patients. The legislation mandates that such testing be covered when recommended by a doctor, board-certified geneticist, or board-certified genetic counselor, and applies to both initial and follow-up diagnoses. Importantly, the bill stipulates that genetic screening will be available not only for patients but also for their family members, and that genetic test results cannot be used against family members for insurance coverage purposes. The coverage is to be provided without annual deductibles or coinsurance, with all associated costs to be paid entirely by the insurance provider. Known as the "Ana Lucia act," this legislation aims to improve access to potentially life-saving genetic screening for prostate and ovarian cancer patients by removing financial barriers to testing. The bill will take effect 60 days after becoming law and will apply to all insurance policies issued or renewed after that date.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A6475